IRIS Accounts Production v23.4.0.336 SC735273 Board of Directors 13.6.22 30.6.23 30.6.23 No description of principal activity false true false false true true Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7352732022-06-12SC7352732023-06-30SC7352732022-06-132023-06-30SC7352732022-06-12SC735273ns15:Scotland2022-06-132023-06-30SC735273ns14:PoundSterling2022-06-132023-06-30SC735273ns10:Director12022-06-132023-06-30SC735273ns10:PrivateLimitedCompanyLtd2022-06-132023-06-30SC735273ns10:SmallEntities2022-06-132023-06-30SC735273ns10:AuditExempt-NoAccountantsReport2022-06-132023-06-30SC735273ns10:SmallCompaniesRegimeForDirectorsReport2022-06-132023-06-30SC735273ns10:SmallCompaniesRegimeForAccounts2022-06-132023-06-30SC735273ns10:FullAccounts2022-06-132023-06-30SC735273ns10:OrdinaryShareClass12022-06-132023-06-30SC735273ns10:OrdinaryShareClass112022-06-132023-06-30SC735273ns10:Director32022-06-132023-06-30SC735273ns10:RegisteredOffice2022-06-132023-06-30SC735273ns5:ShareCapital2023-06-30SC735273ns10:OrdinaryShareClass12023-06-30
REGISTERED NUMBER: SC735273 (Scotland)















Unaudited Financial Statements

for the Period 13 June 2022 to 30 June 2023

for

Cojent Ltd

Cojent Ltd (Registered number: SC735273)






Contents of the Financial Statements
for the Period 13 June 2022 to 30 June 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Cojent Ltd

Company Information
for the Period 13 June 2022 to 30 June 2023







DIRECTORS: Dr Cemal Kavasogullari
Christian Barry





REGISTERED OFFICE: 25 Sandyford Place
Glasgow
G3 7NG





REGISTERED NUMBER: SC735273 (Scotland)

Cojent Ltd (Registered number: SC735273)

Balance Sheet
30 June 2023

Notes £   
CURRENT ASSETS
Cash in hand 100
TOTAL ASSETS LESS CURRENT
LIABILITIES

100

CAPITAL AND RESERVES
Called up share capital 4 100
SHAREHOLDERS' FUNDS 100

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the period ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2024 and were signed on its behalf by:





Christian Barry - Director


Cojent Ltd (Registered number: SC735273)

Notes to the Financial Statements
for the Period 13 June 2022 to 30 June 2023

1. STATUTORY INFORMATION

Cojent Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Grant income
Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 3 .

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100 Ordinary £1 100

100 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

5. ULTIMATE CONTROLLING PARTY

The company is under the control of Est-Ethics Ltd and Taleta Pharma Ltd.